Australian Medical Cannabis Company MGC Says It Now Has 1800 Prescribed Products
Cannabis Law Report
DECEMBER 18, 2019
Notably, the increase comes after the company recently broke into the European pharma-market after getting green-lighted from the Irish Government to sell its phytocannabinoid-derived “CannEpil” product to epilepsy sufferers. Both products are proprietary medicinal drugs developed internally through MGC’s research and development divisions.
Let's personalize your content